CA2355607A1 - Anti-ccr5 antibody - Google Patents

Anti-ccr5 antibody Download PDF

Info

Publication number
CA2355607A1
CA2355607A1 CA002355607A CA2355607A CA2355607A1 CA 2355607 A1 CA2355607 A1 CA 2355607A1 CA 002355607 A CA002355607 A CA 002355607A CA 2355607 A CA2355607 A CA 2355607A CA 2355607 A1 CA2355607 A1 CA 2355607A1
Authority
CA
Canada
Prior art keywords
composition
hiv
compounds
antibody
ccr5
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002355607A
Other languages
English (en)
French (fr)
Inventor
William C. Olson
Paul J. Maddon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Progenics Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2355607A1 publication Critical patent/CA2355607A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002355607A 1998-12-16 1999-12-16 Anti-ccr5 antibody Abandoned CA2355607A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21279398A 1998-12-16 1998-12-16
US11253298P 1998-12-16 1998-12-16
US09/212,793 1998-12-16
US60/112,532 1998-12-16
PCT/US1999/030345 WO2000035409A2 (en) 1998-12-16 1999-12-16 Hiv-i fusion inhibition compounds

Publications (1)

Publication Number Publication Date
CA2355607A1 true CA2355607A1 (en) 2000-06-22

Family

ID=26810060

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002355607A Abandoned CA2355607A1 (en) 1998-12-16 1999-12-16 Anti-ccr5 antibody

Country Status (13)

Country Link
EP (2) EP1144006B1 (https=)
JP (1) JP2002538771A (https=)
AT (1) ATE375802T1 (https=)
AU (3) AU773175B2 (https=)
CA (1) CA2355607A1 (https=)
CY (1) CY1107858T1 (https=)
DE (1) DE69937369T2 (https=)
DK (1) DK1144006T3 (https=)
ES (1) ES2296416T3 (https=)
HK (1) HK1041207B (https=)
MX (1) MXPA01006097A (https=)
PT (1) PT1144006E (https=)
WO (1) WO2000035409A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0847452B1 (en) 1995-06-07 2009-04-01 Progenics Pharmaceuticals, Inc. Monoclonal antibody for inhibiting hiv-1 envelope glycoprotein mediated membrane fusion
US7118859B2 (en) 1996-01-17 2006-10-10 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
AU2265701A (en) * 1999-12-16 2001-06-25 Tanox, Inc. Anti-hiv-1 conjugates for treatment of hiv disease
US7138119B2 (en) 2000-09-15 2006-11-21 Progenics Pharmaceuticals, Inc. Compositions and methods for inhibition of HIV-1 infection
US7060273B2 (en) 2001-04-06 2006-06-13 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
US20020146415A1 (en) * 2001-04-06 2002-10-10 Olson William C. Methods for inhibiting HIV-1 infection
US20060078537A1 (en) * 2001-12-21 2006-04-13 Matthias Mack Mono-and dual chemokine/cytokine constructs
DE60324664D1 (de) * 2002-02-22 2008-12-24 Pdl Biopharma Inc Anti-ccr5 antikörper
US7122185B2 (en) 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
TW200720289A (en) 2005-04-01 2007-06-01 Hoffmann La Roche Antibodies against CCR5 and uses thereof
JP2009525301A (ja) * 2006-01-30 2009-07-09 エフ．ホフマン−ラ ロシュ アーゲー Ｈｉｖを処置するための相乗的組成物
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
AU2007286451A1 (en) 2006-08-17 2008-02-21 F. Hoffmann-La Roche Ag A conjugate of an antibody against CCR5 and an antifusogenic peptide
KR20090052358A (ko) 2006-09-29 2009-05-25 에프. 호프만-라 로슈 아게 Ｃｃｒ5 에 대한 항체 및 이의 용도
CL2008000707A1 (es) 2007-03-13 2008-09-22 Hoffmann La Roche Conjugado de polipeptidos antifusogenicos y polipeptidos derivados de la cabeza globular del factor del complemento c1q; composicion farmaceutica que lo comprende; su uso para tratar infecciones viricas; y metodo de produccion.
EP2741777B1 (en) 2011-08-12 2017-01-18 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for treatment of pulmonary hypertension
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3375697A (en) * 1996-05-28 1998-01-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cc chemokine receptor 5, antibodies thereto, transgenic animals
AU735460B2 (en) * 1996-06-14 2001-07-12 Aaron Diamond Aids Research Center, The Uses of a chemokine receptor for inhibiting HIV-1 infection
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same

Also Published As

Publication number Publication date
AU2004205165A1 (en) 2004-09-16
EP2088158A2 (en) 2009-08-12
AU2004205164A1 (en) 2004-09-16
JP2002538771A (ja) 2002-11-19
PT1144006E (pt) 2007-12-11
EP1144006A4 (en) 2004-11-24
DE69937369T2 (de) 2008-07-24
AU2199600A (en) 2000-07-03
HK1041207B (en) 2007-12-28
EP1144006A2 (en) 2001-10-17
ATE375802T1 (de) 2007-11-15
DK1144006T3 (da) 2007-11-26
DE69937369D1 (de) 2007-11-29
HK1041207A1 (en) 2002-07-05
WO2000035409A3 (en) 2000-09-14
AU773175B2 (en) 2004-05-20
ES2296416T3 (es) 2008-04-16
CY1107858T1 (el) 2013-06-19
EP1144006B1 (en) 2007-10-17
MXPA01006097A (es) 2002-04-15
WO2000035409A2 (en) 2000-06-22
EP2088158A3 (en) 2010-01-20

Similar Documents

Publication Publication Date Title
US7060273B2 (en) Methods for inhibiting HIV-1 infection
US20070231327A1 (en) Anti-CCR5 antibodies
US7666419B2 (en) Anti-CCR5 antibody
US20020146415A1 (en) Methods for inhibiting HIV-1 infection
EP1144006B1 (en) CCR5 Antibody PA14
AU2003217674B2 (en) Anti-CCR5 antibody
US20080015348A1 (en) Nucleic acids encoding polypeptides of anti-CCR5 antibodies
AU2007254697B2 (en) Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto-I
EP1900376A2 (en) Synergistic inhibition of HIV-1 fusion and attachment, compsitions and antobodies thereto
HK1117065A (en) Synergistic inhibition of hiv-1 fusion and attachment, compsitions and antobodies thereto
HK1133020A (en) Monoclonal antibody against the ccr5 chemokine receptor
HK1131343A (en) Anti-ccr5 antibody
HK1072272B (en) Anti-ccr5 antibody

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued